Grant: Project Grant
University of Alberta
$948,600.00
Improving Corneal Endothelial Cell Adhesion
EF 2017-18
Résumé
Fuchs endothelial corneal dystrophy is a genetic disease of the inner layer of the cornea, called the endothelium. It affects 4% of people to various degrees in their lifetime. Symptoms are progressive, leading to severe eye pain and cloudy vision if left untreated. At present the only effective treatment available for these eyes is corneal transplantation. Unfortunately donor corneas are in short supply, meaning that individuals are often forced to wait until their symptoms are severe before receiving their required transplant. This application proposes to develop ways to improve corneal endothelial cell health, by increasing the degree to which these cells adhere to the patient's own cornea. This new approach may allow treatment of patients earlier and eventually to postpone their corneal transplantation for several years. This new approach could also benefit tissue engineering techniques, allowing one donor cornea to be used to generate several corneal transplants that would treat several patients.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
368194
Name
Casey Joseph (Joe) R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Improving Corneal Endothelial Cell Adhesion
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$948,600
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Adhesion; Congenital Hereditary Endothelial Dystrophy; Cornea; Corneal Dystrophy; Descemet'S Membrane; Fuchs Endothelial Corneal Dystrophy; Mouse Model; Slc4a11; Viral Transduction
Abstract
Fuchs endothelial corneal dystrophy is a genetic disease of the inner layer of the cornea, called the endothelium. It affects 4% of people to various degrees in their lifetime. Symptoms are progressive, leading to severe eye pain and cloudy vision if left untreated. At present the only effective treatment available for these eyes is corneal transplantation. Unfortunately donor corneas are in short supply, meaning that individuals are often forced to wait until their symptoms are severe before receiving their required transplant. This application proposes to develop ways to improve corneal endothelial cell health, by increasing the degree to which these cells adhere to the patient's own cornea. This new approach may allow treatment of patients earlier and eventually to postpone their corneal transplantation for several years. This new approach could also benefit tissue engineering techniques, allowing one donor cornea to be used to generate several corneal transplants that would treat several patients.
Competitiondate
201709
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Casey, Joseph (Joe) R; Brunette, Isabelle; Proulx, Stéphanie
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $948,600~ $0~